Youmanitarian
Youmanitarian 11 Jun 2021

Bir sonraki

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 13 Görünümler

Defining Progression in Metastatic Kidney Cancer

10 Görünümler
TAKE ACTION
Donations would go to support charities for Nasıl Yapılır ve Stil

Panelists Robert A. Figlin, MD; Michael R. Harrison, MD; David I. Quinn, MBBS, PhD; and Eric Jonasch, MD, discuss defining clinical progression and optimizing use of VEGF TKI therapy to achieve the highest dose intensity before switching in patients with metastatic kidney cancer.

Daha fazla göster
More ways to take action
Explore ways that you can help bring a solution to this issue.

Bir sonraki

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 13 Görünümler